Potentiation of glucose elimination
US9801925B2 · kind B2 · utility
0Cited by
881References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2015 |
| Grant date | Oct 31, 2017 |
| Priority date | — |
| Expiry date | Oct 1, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods related to the treatment of diabetes and improving the efficiency of insulin utilization are provided. The method enables effective control of prandial glucose levels while reducing the risk of postprandial hypoglycemia. In particular, methods of potentiating the activity of endogenous insulin in type 2 diabetics and exogenous long-acting insulin in diabetics requiring basal insulin replacement are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.